Garvan Institute of Medical Research

The Cancer Plasticity and Dormancy Program is focused on discovering the fundamental control mechanisms that regulate cancer cell dormancy and cancer relapse. Our goal is to develop tools to predict relapse and develop new treatments to stop relapse before it occurs. There is a focus

The Cancer Plasticity and Dormancy Program is focused on discovering the fundamental control mechanisms that regulate cancer cell dormancy and cancer relapse. Our goal is to develop tools to predict relapse and develop new treatments to stop relapse before it occurs. There is a focus

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t